Kirin Holdings Company, Limited (Kirin Holdings) has been recognized as an SX Brand by the Ministry of Economy, Trade and Industry (METI) and the Tokyo Stock Exchange (TSE). SX Brands, which stand for Sustainability Transformation, are chosen by METI and the TSE from among companies listed on the TSE. These awards are granted to companies that actively engage in constructive dialogue with investors and other stakeholders to address society’s sustainability challenges and integrate them into their growth strategies, thereby promoting necessary corporate management and business transformation.
The selection process identifies leading companies committed to creating long-term, sustainable corporate value by incorporating society’s sustainability concerns into their growth plans through constructive engagement with investors and stakeholders. Such companies also demonstrate a willingness to implement management reforms and drive business transformation in line with these sustainability objectives.
Kirin Holdings, guided by its Long-Term Management Vision, Kirin Group Vision 2027 (KV2027), aims to become a global leader in CSV (Creating Shared Value) by generating value across its diverse portfolio spanning from Food & Beverages to Pharmaceuticals. Embracing Group-wide CSV management, Kirin Holdings pursues its CSV Purpose, a guideline for co-creating value with society and achieving sustainable growth, by striving to create both economic and social value through its business operations.
KV2027 has been lauded for its forward-thinking approach, envisioning Kirin Holdings’ future positioning as a global CSV leader amidst evolving market dynamics such as maturing beer markets in developed countries and the growing trend of craft and premiumization globally. Furthermore, the KV2027 business plan has received acclaim for setting ambitious goals across all three business domains, leveraging the company’s core competencies in fermentation and biotechnology, which have been integral since its inception.
In line with its vision of becoming a global leader in CSV, Kirin Holdings has been commended for its efforts to expand its presence in the Health Science domain, bridging the realms of Food & Beverages and Pharmaceuticals. Leveraging its expertise in fermentation and biotechnology, Kirin Holdings aims to bolster its Health Science business, exploring new ventures and unique materials like Lactococcus lactis strain Plasma [postbiotic] (LC-Plasma).
Recognizing the pivotal role of human capital in executing its management strategy, Kirin Holdings places great importance on developing a workforce characterized by expertise and diversity. As the company evolves its business portfolio, enhancing organizational capabilities and adaptability becomes paramount in both the short and long term. Kirin Holdings’ commitment to nurturing diverse perspectives and values, coupled with initiatives such as cross-functional personnel transfers and opportunities for employees to undertake diverse challenges, has earned accolades for its strategic approach to human capital development.
